News Roundup: May 29 to June 2
Drug Topics
JUNE 3, 2023
Your weekly roundup of the latest news from Drug Topics®.
Sat.Jun 03, 2023
247 
Analysis of Gut Microbiome Did Not Show Significant Differences Relating to Immune Checkpoint Inhibition Resistance
Pharmacy Times
JUNE 3, 2023
Fecal microbiota transplant from responders to non-responders was able to rescue immune checkpoint inhibition use in patients with melanoma, with 40% of patients showing clinical benefit.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
ASCO: Novartis touts Kisqali adjuvant breast cancer data
pharmaphorum
JUNE 3, 2023
ASCO: Novartis touts Kisqali adjuvant breast cancer data Phil.
New Manufacturing Process Could Improve CAR T Cell Efficacy Against Aggressive Form of Leukemia
Pharmacy Times
JUNE 3, 2023
Expert said that manufacturing the T cells with a tyrosine kinase inhibitor may allow more patients to get allogeneic stem cell transplant, the current best means of long-term cure.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
ASCO: Seagen's top-selling drug under threat as Bristol Myers' Opdivo beats Adcetris in lymphoma
Fierce Pharma
JUNE 3, 2023
The rising antibody-drug conjugate class has hit a setback as Seagen’s Adcetris, one of the earliest and fast-growing members of the group, was defeated by immune checkpoint inhibitor. | The rising antibody-drug conjugate class has hit a setback as Seagen’s Adcetris, one of the earliest and fast-growing members of the group, was defeated by immune checkpoint inhibitor in classical Hodgkin lymphoma.
Expert: Genomic Testing Can Help Oncologists Customize Treatment Based on the Tumor Type
Pharmacy Times
JUNE 3, 2023
Identifying alterations in tumor genes has enabled medical oncologists to guide patients towards more specific therapies.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Tumor Fraction Retains Strong Prognostic Value for Advanced Non-small Cell Lung Cancer
Pharmacy Times
JUNE 3, 2023
High tumor fraction after induction chemotherapy identifies a population with an unmet need who has low chances to benefit from immune checkpoint blockades.
Cross-border ‘twinning programs’ may reduce survival disparities for childhood leukemia
STAT
JUNE 3, 2023
CHICAGO – A few miles can mean a life or death difference to children with cancer, if those miles cross a national border. “Twinning programs” helped to reduce survival disparities in childhood acute leukemia between high income and lower income countries, according to a study presented here at the American Society of Clinical Oncology on Saturday.
Let's personalize your content